Diabetes / chronic diseases Research and Management Tool

Strategy

Research, developing solutions or possible solutions then causing a lot of noise to get something done by corporations who are more specialized in the area of health sciences.

Activities and products

My work was pertaining to creating a digitally networked Research and Management tool, that interacted with the blood sampling unit, and contained the food database (glucose levels, etc) exercise and other affiliated information inputs.  The model I was seeking was for Cellular PDA’s to be distributed for a government-discounted fee, allowing patents to enter their disease-affiliated information.

This information would then be used by the patents doctors, to help better manage the patent, and by researchers who if coupled with an advanced database solution would be able to make quantitive analysis studies on current treatment, Drug trials and accelerate Future treatment and analysis.

Chronic Diseases – Mobile Info System

Diabetes & other Diseases mobile reporting system (research, Case Management)

“The ability to Monitor & Report status for Medical requirements.”

This will decrease the time required in developing drugs, cures & other beneficial development in treatments;

IE; Diabetes

-          Food Intake

-          Carb’s

-          Weight

-          Glucose levels (up to 10 – 12 times per date)

-          What types of Drugs currently on

-          Amount of drugs taken

-          Amount of Exercise

-          Time of each event occurring

The idea behind this type of Solution is to enable medical researchers & medical practitioners with an electronic feeds of what their customers behaviours are & how their disabilities / diseases etc. are being affected by the prescribed treatments.  The outcomes from implementation of systems such as the above is the ability to accelerate the curve on treatment & drug development innovations via reporting the effects in an electronically managed, distributed & analysed environments.

Current status is working on the requirements for a Diabetes based program to be developed for beta-testing